LLY
742.34
+2.24%↑
UNH
524.47
+2.96%↑
JNJ
148.01
+0.7%↑
ABBV
172.39
+0.6%↑
NVO
80.97
+2.85%↑
LLY
742.34
+2.24%↑
UNH
524.47
+2.96%↑
JNJ
148.01
+0.7%↑
ABBV
172.39
+0.6%↑
NVO
80.97
+2.85%↑
LLY
742.34
+2.24%↑
UNH
524.47
+2.96%↑
JNJ
148.01
+0.7%↑
ABBV
172.39
+0.6%↑
NVO
80.97
+2.85%↑
LLY
742.34
+2.24%↑
UNH
524.47
+2.96%↑
JNJ
148.01
+0.7%↑
ABBV
172.39
+0.6%↑
NVO
80.97
+2.85%↑
LLY
742.34
+2.24%↑
UNH
524.47
+2.96%↑
JNJ
148.01
+0.7%↑
ABBV
172.39
+0.6%↑
NVO
80.97
+2.85%↑
24h
Actual
Mínimo
66.62
Máximo
68.37
Recomendaciones | Compra Fuerte |
---|---|
Estimación a 12 meses | +33.15 upside |
By Trading Central
Confianza
Very Strong Bullish Evidence
65.64 / 66.61 Soporte y Resistencia
El rendimiento pasado no es un indicador fiable de resultados futuros.
24 dic 2024, 15:24 UTC
Achilles Therapeutics Sells Technology Assets to AstraZeneca for $12 Million
DJ
Leer
12 nov 2024, 19:55 UTC
AstraZeneca Expands U.S. Investment Plan -- 3rd Update
DJ
Leer
12 nov 2024, 11:02 UTC
AstraZeneca Raises Outlook, Plans U.S. Investment -- Update
DJ
Leer
12 nov 2024, 07:37 UTC
AstraZeneca Raises Outlook on Earnings, Sales Beat
DJ
Leer
20 ene 2025, 08:02 UTC
AstraZeneca Trial Results In Focus Amid China Sales Concerns -- Market Talk
DJ
Leer
18 nov 2024, 10:33 UTC
Pharmaceutical Sector Outlook for 2025 Looks Rocky -- Market Talk
DJ
Leer
15 nov 2024, 13:08 UTC
Trump's RFK Pick Weighs on Vaccine Makers -- WSJ
DJ
Leer
15 nov 2024, 10:29 UTC
Stocks to Watch Friday: Tesla, Domino's, Palantir, Ulta -- WSJ
DJ
Leer
12 nov 2024, 15:30 UTC
AstraZeneca Expands U.S. Investment Plan -- 2nd Update
DJ
Leer
12 nov 2024, 13:39 UTC
AstraZeneca's Results Make $80B Revenue Target Look Achievable -- Market Talk
DJ
Leer
12 nov 2024, 10:49 UTC
AstraZeneca Seen With Positive Momentum at Pivotal Period -- Market Talk
DJ
Leer
12 nov 2024, 09:52 UTC
AstraZeneca's New Guidance Could Imply Consensus Upgrades -- Market Talk
DJ
Leer
12 nov 2024, 07:02 UTC
AstraZeneca Had Seen 2024 Core EPS Growth by Mid Teens Percentage Range
DJ
Leer
12 nov 2024, 07:02 UTC
AstraZeneca Sees 2024 Core EPS Growth In High Teens Percentage Range
DJ
Leer
12 nov 2024, 07:02 UTC
AstraZeneca Had Seen 2024 Total Revenue Growth In Mid Teens Percentage Range
DJ
Leer
12 nov 2024, 07:02 UTC
AstraZeneca Sees 2024 Total Revenue Growth In High Teens Percentage Range
DJ
Leer
12 nov 2024, 07:02 UTC
AstraZeneca Raises 2024 View
DJ
Leer
12 nov 2024, 07:01 UTC
Analysts Saw AstraZeneca 3Q Sales at $13.1B
DJ
Leer
12 nov 2024, 07:01 UTC
Analysts Saw AstraZeneca 3Q Core EPS at $2.04
DJ
Leer
12 nov 2024, 07:00 UTC
AstraZeneca PLC 3Q EPS 91c
DJ
Leer
12 nov 2024, 07:00 UTC
AstraZeneca PLC 3Q Net Pft $1.43B
DJ
Leer
12 nov 2024, 07:00 UTC
AstraZeneca PLC 3Q Oper Pft $2.11B
DJ
Leer
7 nov 2024, 08:03 UTC
China Has Detained a Senior AstraZeneca Executive -- Update
DJ
Leer
6 nov 2024, 18:55 UTC
China Has Detained Senior AstraZeneca Executive -- WSJ
DJ
Leer
1 nov 2024, 03:00 UTC
U.S. Drugmakers Are Breaking Up With Their Chinese Supply-Chain Partners -- WSJ
DJ
Leer
31 oct 2024, 19:48 UTC
AstraZeneca Probe in China Adds to Concerns for Foreign Businesses -- Update
DJ
Leer
31 oct 2024, 14:43 UTC
AstraZeneca Probe in China Adds to Concerns for Foreign Businesses -- WSJ
DJ
Leer
12 sept 2024, 17:01 UTC
The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- Update
DJ
Leer
12 sept 2024, 11:00 UTC
The Brawl Taking Shape Over Pfizer's Multibillion-Dollar Heart Monopoly -- Heard on the Street -- WSJ
DJ
Leer
10 sept 2024, 13:08 UTC
AstraZeneca's Lung Cancer Drug Candidate Disappoints, Lowering Probability of FDA Approval -- Market Talk
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 88.68 USD 33.15%
Máximo 91.7 USD
Mínimo 87 USD
De acuerdo con 5 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para AstraZeneca PLC ADR Dist en los últimos 3 meses.
By TipRanks
Compra Fuerte
5 ratings
5
Comprar
0
Mantener
0
Vender
De acuerdo con 5 analistas que ofrecen calificaciones bursátiles a para AstraZeneca PLC ADR Dist en los últimos 3 meses.
By Trading Central
Corto Plazo
Very Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Medio plazo
Weak Bearish Evidence
Recent bearish events outweigh bullish events.
Largo Plazo
Weak Bearish Evidence
Bearish events outweigh bullish events.
$